151
Views
0
CrossRef citations to date
0
Altmetric
Special Report

Awareness Survey of Parties Involved in Pharmacogenomics in Japan

, &
Pages 275-286 | Published online: 27 Feb 2007

Bibliography

  • Sumino Y , MiyagijimaT: Research on pharmacokinetic-related genetic polymorphisms in Japanese. Establishment of Pharma SNP Consortium (PSC) by Japan Pharmaceutical Manufacturers Association.Faruaw35(12) , 1086 (2000).
  • Japan Health Sciences Foundation: Survey and Prospective Research Project Report (Survey on Basic Technology in Japan) – Prospects for Medical Needs in 2010. Tokyo, Japan (2001).
  • Japan Health Sciences Foundation: Survey Report: Toward Clinical Application of Genomics. Tokyo, Japan (2003).
  • Japan Health Sciences Foundation: Regulatory Trends Survey Report. Prospects for Regulatory Science: Discussions and Proposals Based on Questionnaire Survey. Tokyo, Japan (2006).
  • Japan Health Sciences Foundation: Survey and Prospective Research Project Report (Survey on Basic Technology in Japan) – Prospects for Medical Needs in 2015. Tokyo (2006).
  • Melzer D , RavenA, DetmerDE, LingT, ZimmernRL: My Very Own Medicine: What Must I Know? Information Policy for Pharmacogenetics. Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (2003).
  • Hopkins MM , IbarretaD, GaisserS et al.: Putting pharmacogenetics into practice. Nat. Biotech.24 , 403–410 (2006).
  • Nuffield Council on Bioethics: Pharmacogenetics: Ethical Issues. Bob Hepple (Chair), Nuffield Council, London, UK (2003)
  • Royal Society: Personalised Medicines: Hopes and Realities. David Weatherall (Chair), Royal Society, London, UK (2005).
  • Ministry of Health, Labour and Welfare: Submission of Information to Regulatory Authorities for Preparation of Guidance for the Use of Pharmacogenomics in Clinical Trials. (2005).

Websites

  • Millennium Project (New 1000-Year Project). Decided by the Prime Minister on December 19, 1999 (Japanese). www.kantei.go.jp/jp/mille/991222millpro.pdf
  • Japan Health Sciences Foundation. www.jhsf.or.jp/English/index_e.html
  • Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare; Ministry of Economy, Trade and Industry: Ethical Guidelines for Human Genome/Genes Analysis Research. (2005). www.mext.go.jp/a_menu/shinkou/seimei/genomeshishin/05062701.htm
  • Ministry of Health, Labour and Welfare: The 3rd Science and Technology Basic Plan. (2006). www.mhlw.go.jp/shingi/2006/02/dl/s0201-5b1.pdf
  • White C, Meunier J, SteelFisher G: Public Perception of Genomics/Genetic Testing: CGAT Survey Results (2005). www.pharmaweek.com/Exclusive_Content/11_4.asp
  • National Academy of Clinical Biochemistry: Guidelines and Recommendations for Laboratory Analysis and Application of Pharmacogenetics to Clinical Practice. Draft version 60806. www.aacc.org/NR/rdonlyres/AE772314-08C0-4F75-9895-D40B7181E4F8/0/LMPG_Pharmacogenetics.pdf
  • Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association: Points to Consider in Application of Pharmacogenomics in Clinical Trials on Drugs (draft) (2005). www.okusuri.org/
  • International Conference on Harmonization Steering Committee latest press release. Chicago, IL, USA (2006). www.ich.org/cache/compo/276-254-1.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.